Quick-Neuron™ Dopaminergic - Human iPSC-derived Neurons Alzheimer's Disease - (M, 68yr, Caucasian, not Latino)

from Alzheimer's Disease patient (M, 68)
As low as ¥366,000.00
Our proprietary transcription factor-based stem cell differentiation method produces neurons without a genetic footprint. Quick-Neuron™ Dopaminergic - Human iPSC-derived Neurons display typical neurite outgrowth and express a variety of neuronal markers, such as TUBB3 (pan-neuronal) and TH (dopaminergic). When thawed and maintained according to the instructions in the user guide, the iPSC-derived neurons are viable long-term and are suitable for a variety of characterization and neurotoxicity assays.
More Information
Short Description from Alzheimer's Disease patient (M, 68)
Product Components Component N, Component P, Component D4, Component D5, and Component D6
Starting Material iPSCs derived from peripheral blood mononuclear cells (CIRM line CW50113)
Product Use This product is for research use only. It is not approved for use in humans or for therapeutic or diagnostic use.
Storage Conditions Frozen cells should be stored in liquid (vapor phase). The rest of the components should be stored at -20°C.
Cell Type Dopaminergic Neurons
Culture Type Feeder Cell-Free
Disease Alzheimer's Disease
Donor Sex Male
Donor Race Ethnicity Caucasian, not Latino
Patient History See Resources section for more information.
Reprogramming Method Episomal vector
Induction Method Transcription factors delivered by synthetic mRNA
Growth Properties Adherent
Shipping Conditions Dry ice (domestic) or liquid nitrogen (international)
Shelf Life 1 year
Donor Age At Sampling 68